One of the many aggressive and disastrous forms of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that it is usually detected in its late stages at which time it is more difficult to make treatments.
As the effects of neuroendocrine colon cancer become visible only in the most advanced stages the rate of survival of the patient drops drastically the tumors are always malignant, and mostly detected with distant metastases. Surveys show reports reveal that most of the cases of neuroendocrine cancer end with the death of the patient.
Though the possibilities of neuroendocrine carcinoma in colon are very rare, if unfortunately one is affected by this disease, the health of the patient becomes worse than patients who suffer from adenocarcinoma.
Research reveals that the end results surrounding this form of cancer do not differ with age, sex or tumour location. Though neuroendocrine colon carcinoma depends on which stage the tumour is in Standard cases have revealed that people in stage 1 and 2 of cancer usually do not suffer from neuroendocrine colon cancer. But alternately in several cases, if said tumour is in stage 3 or 4, it is a laborious and hard task the neuroendocrine colon carcinoma.
Unfortunately, medical science has developed no adequate methods to deal with this particular cancer. A more common technique that doctors might use is immunohistochemical staining methods. This method assists doctors in dealing with the severity of the neuroendocrine colon cancer and helps to determine the most helpful medication and treatment for it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. It involves the staining of the tumor with a monoclonal antibody A-80 which will help in the identification of the quantum of neuroendocrine differentiation and nature of the damage on the health of the patient.
Neuroendocrine colon carcinoma is hard to treat and a case study in which several patients suffered from this particular disease was examined, it was noted that the average survival rate for this disease was in most cases, seven months. In the later stages these rates decrease, to as low as five months or less. Most of these cases were initially detected as carcinoids but they soon became in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a bad prognosis and surgery is not always a guaranteed treatment so surgery may not even cure the patient. So it is critical to make note of carcinoma quickly and administer the proper treatment.